Profiel
Jaime Uribe de la Mora currently works at Probiomed SA de CV, as Chief Executive Officer.
Actieve functies van Jaime Uribe de la Mora
Bedrijven | Functie | Begin |
---|---|---|
Probiomed SA de CV
Probiomed SA de CV Pharmaceuticals: MajorHealth Technology Probiomed SA de CV develops and manufactures pharmaceutical products. Develop high quality products to resolve health problems in an effective and economic way, from their capacity in biotechnology, with a high national integration and added value. PROBIOMED is a pioneering firm in Mexico that produces drugs through recombinant DNA technology, such as efficient way cancer, AIDS, hepatitis B and C, as well as organic insufficiencies such as kidney failure, to mention just a few. Its goal is to use its biotechnological capacity to develop products of the very highest quality so as to solve health problems in an efficient manner. Its biotechnological capacity is almost entirely domestic, since neither raw materials nor intermediate products are imported. The company was founded in 1970 and is headquartered in Mexico City, Mexico. | Algemeen Directeur | 20-09-2011 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Probiomed SA de CV
Probiomed SA de CV Pharmaceuticals: MajorHealth Technology Probiomed SA de CV develops and manufactures pharmaceutical products. Develop high quality products to resolve health problems in an effective and economic way, from their capacity in biotechnology, with a high national integration and added value. PROBIOMED is a pioneering firm in Mexico that produces drugs through recombinant DNA technology, such as efficient way cancer, AIDS, hepatitis B and C, as well as organic insufficiencies such as kidney failure, to mention just a few. Its goal is to use its biotechnological capacity to develop products of the very highest quality so as to solve health problems in an efficient manner. Its biotechnological capacity is almost entirely domestic, since neither raw materials nor intermediate products are imported. The company was founded in 1970 and is headquartered in Mexico City, Mexico. | Health Technology |